GET THE APP

Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+44 1223 790975

Drug Designing: Open Access : Citations & Metrics Report

Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Drug Designing: Open Access.

  2021 2020 2019 2018 2017 2016

Year wise published articles

31 67 2 5 16 18

Year wise citations received

50 43 38 38 22 46
Journal total citations count 368
Journal impact factor 1.70
Journal 5 years impact factor 1.5
Journal cite score 1.57
Journal h-index 9
Journal h-index since 2018 7
Important citations (297)

Effect of thyroid hormones on glucose homeostasis

Tablets manufacturing methods and granulation techniques

Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design

Analytical similarity assessment in biosimilar studies.

Challenging issues in assessing analytical similarity in biosimilar studies

Statistical considerations in demonstrating cmc analytical similarity for a biosimilar product

Statistical approaches to assess biosimilarity from analytical data

On the establishment of equivalence acceptance criterion in analytical similarity assessment.

Sample size requirement in analytical studies for similarity assessment.

On the glycosylation aspects of bio similarity

Pragmatic rules for comparability of biological medicinal products.

on statistical approaches for demonstrating analytical similarity in the presence of correlation

Potent biological agent benzimidazole–a review

Synthesis and biological evaluation of some new benzimidazole derivatives bearing dithiocarbamate moiety as potential cholinesterase inhibitors

A review on recent publications using microwaves in synthesis of biologically active molecules

Acetylcholine esterase inhibitory potential of some benzimidazole derivatives

Statistical and regulatory considerations in assessments of interchangeability of biological drug products.

Relevant Topics

Top